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In the current study, it was shown that repressed virus genomes in quiescently infected MRC5
cells adopt a repressed histone-associated structure marked by the enrichment of deacetylated
histones at a wide variety of herpes simplex virus type 1 (HSV-1) promoters. In addition, it was
shown that genome de-repression, mediated by HSV-2 superinfection or delivery of ICP0
using a recombinant adenovirus vector, resulted in the enrichment of acetylated histones on HSV
DNA. These data indicate that ICP0-mediated genome de-repression is intimately linked to
enrichment of acetylated histones at virus promoters. The fold change in association of
pan-acetylated histone H3 following Ad.TRE.ICP0-mediated de-repression consistently revealed
promoter-specific variation, with the highest fold changes (.50-fold) being observed at the
latency-associated transcript promoter and enhancer regions. Chromatin immunoprecipitation
analyses using an antibody specific to the C terminus of histone H3 as a surrogate measure of
nucleosome occupancy revealed little variability in the total loading of histone H3 at the various
HSV promoters. This observation suggests that acetylation of histone H3 in response to ICP0
expression is not uniformly targeted across the HSV-1 genome during ICP0-mediated de-
repression.
INTRODUCTION
Herpes simplex virus (HSV) undergoes productive infec-
tion in epithelial cells leading to access of virus to nerve
terminals and establishment of latency in sensory neurones.
During latency, the virus genome adopts a non-linear
configuration and is transcriptionally repressed with the
exception of a region encoding the latency-associated
transcripts (LATs). The mechanism by which virus
genomes are maintained in a repressed state during latency
and the processes involved in reactivation from latency
remain poorly understood. None the less, there is
compelling evidence that histones play an important role
in the regulation of HSV gene expression during latency.
Analyses of murine brainstem tissue first demonstrated the
nucleosomal organization of latent virus DNA (Deshmane
& Fraser, 1989), and studies of virus reactivation in
neuronal cultures revealed that the immediate-early (IE)
ICP0 promoter is activated by the histone deacetylase
inhibitor trichostatin A (TSA) (Arthur et al., 2001),
implying that latent genomes can respond to changes in
the acetylation status of histones.
It has been established that post-translational modifica-
tions of the N-terminal tails of histones are involved in the
regulation of transcription (Jenuwein & Allis, 2001;
Kouzarides, 2002). Thus, hyperacetylation of histones is
associated with an ‘open chromatin’ conformation and
transcriptional activity, whilst histone hypoacetylation is
associated with condensed chromatin and gene silencing.
Recent work on HSV-1 suggests that chromatinization of
the virus genome and certain accompanying histone
modifications offer a means of regulating virus gene
expression during lytic infection (Herrera & Triezenberg,
2004; Kent et al., 2004). In the context of latency, it is of
significance that studies utilizing chromatin immunopre-
cipitation (ChIP) assays have shown the LAT promoter to
be enriched with acetylated histone H3, whilst represen-
tative lytic cycle promoters exhibit a decreased association
with acetylated histones (Kubat et al., 2004a, b). The
demonstration that acetylated histones are enriched on the
ICP0 promoter following the application of a ganglionic
reactivation stimulus supports the view that genome
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positioned on lytic cycle promoters (Amelio et al., 2006).
Furthermore, data showing that a LAT-deficient mutant
exhibits enrichment of histone modifications associated
with transcriptional activation suggests that virus functions
expressed during latency facilitate maintenance of a
repressed genome (Wang et al., 2005).
In order to facilitate studies of histones associated with
transcriptionally repressed HSV-1 genomes, we have utilized
a fibroblast model of latency based on previously described
systems (Harris & Preston, 1991; Preston & Nicholl, 1997;
Samaniego et al., 1998). In these systems, replication-
defective mutants of HSV-1 are used to infect tissue culture
cells and establish a quiescent infection. Repressed virus
genomes are retained in a non-linear configuration and,
although resistant to a variety of reactivation stimuli, they
can be efficiently de-repressed by superinfection with HSV
or provision of ICP0 in trans (Harris et al., 1989; Zhu et al.,
1990; Preston & Nicholl, 1997; Hobbs et al., 2001). These
studies and the fact that ICP0 null mutants exhibit
reactivation deficits in animal model systems (Leib et al.,
1989; Halford & Schaffer, 2001) has led to interest in the
properties and function of ICP0 that may be of relevance to
the process of reactivation from latency (reviewed by
Everett, 2000; Hagglund & Roizman, 2004; Efstathiou &
Preston, 2005). In the current study, we show that virus
genomes in quiescently infected MRC-5 cells adopted a
repressed histone-associated structure marked by the
enrichment of deacetylated histones and histone H3 lysine
9 (K9) methylation at a variety of HSV-1 promoters. In
addition, we report that genome de-repression mediated by
virus superinfection or delivery of ICP0 using a recombinant
adenovirus resulted in the enrichment of acetylated histones
on HSV DNA. These data indicate that ICP0-mediated
genome de-repression is intimately linked to enrichment of
acetylated histones at virus promoters.
METHODS
Viruses and cells. MRC-5 cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum
(FCS) and 2 mM L-glutamine. Baby hamster kidney (BHK) cells were
cultured in Glasgow minimum essential medium supplemented with
10% FCS, 10% tryptose phosphate broth and 2 mM L-glutamine.
HSV-1 in1382 (Homer et al., 1999) contains a 12 bp insertion within
VP16 abolishing its transactivation function (Ace et al., 1989), a
deletion within the RING finger of ICP0 and a ts mutation within
ICP4. This replication-defective mutant contains the human cyto-
megalovirus (HCMV) major IE promoter (2750 to +7) driving
expression of b-galactosidase inserted at the thymidine kinase gene.
In1383 is identical to in1382 but carries an ICP0 promoter (2850 to
+48) b-galactosidase cassette. In1382 and in1383 stocks were
produced using BHK cells at 31 uC in the presence of 3 mM
hexamethylene bisacetamide as described previously (McFarlane et al.,
1992). dl1403 is an ICP0 deletion mutant derived from HSV strain 17
(Stow & Stow, 1986).
Establishment of quiescently infected MRC-5 cells. MRC-5 cells
were infected with in1382 or in1383 at an m.o.i. of 1 and incubated at
the non-permissive temperature of 39 uC. At 5–6 days post-infection
(p.i.), cells were harvested for ChIP assays of repressed virus genomes
or induced to reactivate by superinfection with HSV-2 strain 333.
Prior to superinfection, cells were incubated for 1 h with 100 mg
phosphonoacetic acid (PAA) ml
21 and then superinfected with 5 p.f.u.
HSV-2 per cell in the presence of PAA. Adenovirus vectors used in
this study were kindly provided by Dr Anna Salvetti (INSERM,
France) and comprised Ad.TRE.ICP0 containing the HSV-1 strain
17 ICP0 gene under the control of the tetracycline-responsive (TRE)
promoter, Ad.TRE.FXE containing a non-functional RING finger
deletion of the HSV-1 strain 17 ICP0 gene, and Ad.CMV.rtTA
encoding the reverse tetracycline transactivator under the control of
the HCMV IE promoter. In these three recombinants, the transgene
was inserted in place of the E1 gene in an E1/E3-deficient backbone.
For b-galactosidase staining, infected MRC-5 cells, either before or
after de-repression, were fixed with 0.5% glutaraldehyde in PBS and
then overlaid with 5-bromo-4-chloro-3-indolyl b-D-galactopyrano-
side (X-gal) solution (0.01% sodium deoxycholate, 0.02% NP-40,
2 mM MgCl2, 1 mg X-gal ml
21, 5 mM potassium ferricyanide and
5 mM potassium ferrocyanide) and incubated at 37 uC for 6 h.
ChIP assays. Cell monolayers were fixed with 1% formaldehyde for
10 min at 37 uC before removal into ice-cold PBS containing EDTA-
free protease inhibitor cocktail (Roche) and 1 mM PMSF (Roche).
Cell pellets (4610
6 cells) were resuspended in 1.2 ml lysis buffer
[50 mM Tris/HCl (pH 8.0), 1% SDS, 10 mM EDTA] containing
protease inhibitors and incubated on ice for 10 min. The cell lysate
was sonicated (Vibracell; Jencons Scientific Ltd) at 40% output twice
for 2 min each to shear the chromatin into a median size range of
500–1000 bp. Aliquots (250 ml) of cell lysate were diluted 10-fold in
dilution buffer [20 mM Tris/HCl (pH 8.0), 1% Triton X-100, 2 mM
EDTA, 150 mM NaCl]. Each aliquot was pre-cleared with 100 ml
protein A–Sepharose beads [0.5 g protein A–Sepharose (Sigma) in
5 ml dilution buffer containing 1 mg salmon sperm DNA ml
21,1m g
BSA ml
21 and 0.02% sodium azide] for 1 h at 4 uC. Volumes of
chromatin (250 ml) were incubated overnight with anti-pan-acety-
lated histone H3 (acetyl K9 and K14) (06-599; Upstate
Biotechnology), anti-histone H3 trimethyl K9 (ab8898; Abcam),
anti-HP1-a (ab9057; Abcam), anti-C-terminal histone H3 (ab1791;
Abcam), anti-pan-acetylated histone H4 (acetyl K4, K7, K11 and K15)
(06-866; Upstate Biotechnology) or anti-pan-acetylated histone H4
(raised against chemically acetylated histone H4) (ab193; Abcam).
Antibody–antigen complexes were isolated with protein A–Sepharose
beads and eluted by incubation with 1% SDS in 0.1 M NaHCO3.
Eluted DNA–protein complexes were incubated with 0.2 M NaCl at
65 uC overnight to reverse the formaldehyde cross-linking and
the DNA was purified by treatment with proteinase K followed by
phenol/chloroform extraction. The DNA was isolated by ethanol
precipitation following the addition of glycogen and tRNA as
carrier.
Standard PCR analyses. The genomic region of interest was
subjected to a maximum of 35 cycles of PCR amplification using
AmpliTaq Gold Polymerase (Roche) using the following primer sets:
ICP0: 59-TATACCCCACGCCTTTCCCC-39 [forward primer (FP), nt
2089–2070] and 59-CCTTGTTCCGCTTCCCGGTA-39 [reverse primer
(RP), nt 1553–1572]; glycoprotein C (gC): 59-GTTTTCCGAGGT-
TGTCGTGT-39 (FP, nt 95830–95849) and 59-GGTCTTCGG-
GACTAATGCCT-39 (RP, nt 96088–96069); LAT promoter:
59-CCCAGAGTCATTGTTTATGTGG-39 (FP, nt 118519–118540):
59-AGCAAAAACAGGCCACAGC-39 (RP, nt 118759–118741). PCRs
on input DNA and bound ChIP fractions were performed
simultaneously and sampled after 20, 25 and 30 cycles. The PCR
conditions were as follows: initial denaturation for 5 min at 95 uC,
cycles of 1 min at 94 uC, 1 min at 55 uC (gC and LAT primers) or
65 uC (ICP0 primers) and 1 min at 72 uC, and a final elongation of
10 min at 72 uC. PCR products were resolved by agarose gel
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radiolabelled probes specific for each amplicon.
Quantitative real-time PCR. Real-time PCR was carried out using a
Rotor-Gene (Corbett Research) in triplicate for each reaction. The
primer sets and Taqman probes employed for amplification of each
virus promoter, given as HSV-1 sequence co-ordinates, were as
follows: ICP0: nt 2072–2090 (FP), nt 2209–2139 (RP), nt 2115–2134
(probe); ICP4: nt 131522–131538 (FP), nt 131747–131730 (RP), nt
131700–131678 (probe); ICP27: nt 113238–113259 (FP), nt 113384–
113367 (RP), nt 113328–113308 (probe); VP16: nt 105408–105436
(FP), nt 105712–105695 (RP), nt 105439–105462 (probe); gC: nt
95689–95707 (FP), nt 95800–95783 (RP), 95756–95777 (probe); LAT
promoter: nt 118248–118267 (FP), nt 118374–118351 (RP), nt
118323–118303 (probe); LAT enhancer: nt 119314–119334 (FP), nt
119425–119405 (RP), nt 119336–119360 (probe). The transcription
start sites for the HSV promoters were as follows: ICP0, nt 2115;
ICP4, nt 131429; VP16, nt 105259; ICP27, nt 113596; gC, nt 96170;
LAT, nt 118801. The following primers were also used: human
GAPDH: nt 1725–1744 (FP), nt 1913–1894 (RP), nt 1749–1773
(probe) (relative to the transcription start site of nt 1874; GenBank
accession no. AY340484); human tumour necrosis factor (TNF)-a:n t
1768–1789 (FP), nt 2262–2241 (RP), nt 1878–1904 (probe) (Nitsche
et al., 2001); human c-globin: nt 1999–2020 (FP), nt 2185–2166 (RP),
nt 2147–2121 (probe) (Bottardi et al., 2003). Primers and HPLC-
purified probes were manufactured by TIB-Molbiol. PCR products
were quantified using a Rotor-Gene and associated software as the
copy number per PCR, calculated from triplicate results from each
PCR. A standard curve for each gene region was generated using
dilutions of appropriate plasmids. The level of association of modified
histones in the original chromatin sample was expressed as the ratio
of immunoprecipitated DNA (IP-DNA) (bound) to the total amount
of DNA in the chromatin sample (input). Fold changes in the
association of histones in uninduced latently infected material in
comparison with associations observed following induction of
reactivation were calculated as the ratio of IP-DNA/input (induced)
to IP-DNA/input (uninduced). The level of association of modified
histones at the human GAPDH region was quantified and expressed
as an IP-DNA/input ratio from which fold changes relative to
uninduced chromatin were calculated. To normalize the fold changes
against human GAPDH, each fold change occurring at a viral
promoter was divided by the fold change occurring at GAPDH in the
corresponding chromatin sample.
RESULTS
Establishment of quiescent infection in MRC-5
cells and reactivation by HSV-2 superinfection
Previous studies have shown that infection of cells in culture
with IE gene-deficient mutants of HSV-1 results in the
establishment of a quiescent state (Harris & Preston, 1991;
Preston & Nicholl, 1997; Samaniego et al., 1998; Minaker
et al., 2005). Quiescent genomes remain functional, as
reactivation can be induced efficiently by provision of ICP0
in trans following superinfection with HSV or recombinant
adenovirus (Zhu et al., 1990; Preston & Nicholl,1997; Hobbs
et al., 2001; Minaker et al., 2005). In order to facilitate
analyses of the chromatin status of HSV DNA during
quiescence and following the induction of reactivation, we
used an MRC-5 cell-based system to generate material for
ChIP analyses. Quiescent infection was established by
infecting MRC-5 cells with replication-defective HSV-1
mutants carrying mutations in the virion transactivator
VP16, ICP0 and tsICP4, and the reporter gene lacZ under the
control of either the HCMV IE promoter (in1382) or the
ICP0 promoter (in1383). Infection of cells at an m.o.i. of 1 at
the non-permissive temperature of 39 uCr e s u l t e di n
transient LacZ expression from the HCMV IE or ICP0
promoter with shut-off evident at day 3 through to day 6 p.i.
(Fig. 1a). Induction of reporter gene expression 6 h after
HSV-2 superinfection demonstrated the retention of func-
tional and responsive virus genomes. The inability of the
HSV-1 ICP0 deletion mutant dl1403 to de-repress and
activate HCMV IE promoter-driven lacZ expression from
MRC-5 cells harbouring quiescent in1382 genomes indicated
an essential requirement for ICP0 in genome de-repression
(Fig. 1b).
The fate of input DNA was evaluated by real-time PCR
analysis of DNA extracted from cells infected at an m.o.i. of
1 with in1382 sampled at 4 and 24 h p.i. and at day 6 p.i.,
either before or after HSV-2 superinfection. HSV-1-specific
ICP0 primers were utilized and, in order to prevent
genome amplification, superinfected monolayers were
cultured in the presence of PAA. A rapid decrease in levels
of virus DNA was evident at early times p.i., with the virus
genome copy number falling from 3572 to 240 copies per
cell between 4 and 24 h p.i. relative to GAPDH. This rapid
decrease in DNA with high DNA input loads is consistent
with previous studies of related replication-defective
mutants (Harris & Preston, 1991; Jamieson et al., 1995).
By 6 days p.i., the virus DNA load had fallen to 169±26.8
Fig. 1. (a) b-Galactosidase staining of MRC-5 cells infected with
in1382 or in1383 at 1, 3 and 6 days p.i. or at 6 days p.i. following
induction by superinfection with HSV-2 strain 333 for 6 h. (b) b-
Galactosidase staining of MRC-5 cells infected with in1382 at
6 days p.i. or at 6 days p.i. following superinfection with either
HSV-1 ICP0 mutant dl1403, wild-type (wt) HSV-1 strain 17 or wt
HSV-2 strain 333 for 4 h.
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appreciably 6 h following genome de-repression
(106±25.9). The relative stability of HSV DNA copy
number before and after de-repression validated the utility
of this experimental system in studies of the chromatin
status of quiescent HSV genomes.
Changes in histone modifications associated with
the HSV-1 genome during quiescence and
de-repression mediated by HSV-2 superinfection
To examine the nature of modified histones associated with
HSV DNA during quiescence and de-repression following
HSV-2 superinfection, histone modifications were exam-
ined using ChIP assays. Our initial attention focused on the
association at the ICP0 promoter of pan-acetylated histone
H4 (AcH4), a marker of transcriptionally active chromatin,
and trimethylation of lysine 9 of histone H3 (TMK9H3), a
marker of repressed chromatin (Jenuwein & Allis, 2001).
An increase in association of AcH4 was observed at the
ICP0 promoter 6 h after HSV-2 superinfection relative to
quiescent genomes (Fig. 2a, lanes 3 and 5). Conversely,
during quiescence, there was a clear association of the
repressive TMK9H3 marker and a detectable decrease in
this modified histone at the ICP0 promoter following
genome de-repression (Fig. 2a, lanes 4 and 6). These results
indicated that acquisition of a repressed state during
quiescence of HSV in MRC-5 cells is associated with a
repressed histone marker (TMK9H3) and that de-repres-
sion following superinfection is associated with histone H4
acetylation at the ICP0 promoter, a representative IE gene
promoter. In order to determine whether the observed
increased association of acetylated histones at the ICP0
promoter following de-repression reflected changes occur-
ring at other genomic loci, we examined the gC late
promoter and the LAT promoter. ChIP analyses revealed
an increased association of AcH4 with antibodies raised
against either H4 acetylated at K4, K7, K11 and K15
(AcH4) (Fig. 2b, lanes 1 and 2), chemically acetylated H4
(Fig. 2b, lanes 3 and 4) or pan-acetylated histone H3
(AcH3; Fig. 2b, lanes 5 and 6). Although differences in
immunoprecipitation efficiencies were observed with these
antibodies, in all cases an increased association of
acetylated histones at virus promoters was evident
following de-repression. The results shown in Fig. 2(b)
(right panel) confirmed that equivalent amounts of input
chromatin from latently infected or superinfected cells
were analysed. No increase in association of acetylated
histones was observed at the human GAPDH promoter
following superinfection, suggesting that the acetylation
status of this transcriptionally active housekeeping pro-
moter is not altered by the de-repressive activity of the
superinfecting virus.
The observation of TMK9H3 association at the ICP0
promoter during quiescence (Fig. 2a, lane 4) is consistent
with virus genomes adopting a heterochromatic state of
silencing, as has been reported previously in studies of
HCMV latency (Murphy et al., 2002; Reeves et al., 2005).
As TMK9H3 binds heterochromatic protein 1 (HP1)
(Bannister et al., 2001), we next determined the association
of HP1 at the ICP0 promoter during quiescence and
following de-repression (Fig. 3). Consistent with our earlier
observations, an increase was observed in the association of
acetylated histone H3 (AcH3) or acetyl K9 of histone H3
(AcK9H3) (Fig. 3a, lanes 1–4) and a modest decrease in
association of TMK9H3 (Fig. 3a, lanes 5 and 6) at the ICP0
promoter following HSV-2 superinfection. Surprisingly,
although an association of HP1 with the ICP0 promoter
was detected during quiescence, an enrichment of HP1 was
observed 6 h following HSV-2 superinfection (Fig. 3, lanes
7 and 8). Examination of a range of virus promoters (ICP0,
ICP27, gC and LAT) by real-time PCR at various times
after superinfection revealed a marked ~10–28-fold change
in AcH3 bound to virus promoters 2 h after super-
infection, consistent with genome de-repression (Fig. 4a).
An increased association of HP1 was also observed at all
promoters, with a maximal ~2.5–3-fold change occurring
2 h post-superinfection (Fig. 4b). This recruitment of HP1
was preceded by a transient enrichment of TMK9H3 at
0.5 h post-superinfection with a maximal ~3.2–5-fold
Fig. 2. (a) ChIP analysis of MRC-5 cells, uninfected (Un) or
latently infected with in1382 and, at 6 days p.i., either super-
infected (+) or not (”) with wt HSV-2 strain 333 for 6 h in the
presence of PAA. Antibodies used were anti-acetyl histone H4
(AcH4) or anti-trimethyl K9 histone H3 (mK9). PCRs were
performed using primers specific for the HSV-1 ICP0 promoter.
(b) Left panel: ChIP analysis of MRC-5 cells latently infected with
in1382 and, at 6 days p.i., either superinfected (+) or not (”) with
wt HSV-2 strain 333 for 6 h in the presence of PAA. Antibodies
used were anti-acetyl histone H4 (AcH4), chemically acetylated
H4 (AcH4
a) or anti-acetyl histone H3 (acetyl K9 and K14) (AcH3).
PCRs were performed using primer sets to the ICP0, LAT, gC or
GAPDH promoters. Right panel: PCRs using ICP0 primers on
input chromatin.
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TMK9H3 and HP1 are generally considered to represent
marks of transcriptionally repressed chromatin; it is
therefore likely that their association with virus promoters
represents an early response to superinfection with HSV-2
rather than de-repression mediated by ICP0 alone. It was
therefore of interest to determine the impact of ICP0
expression on both the association of modified histones
and HP1 recruitment to virus promoters in isolation using
adenovirus vectors expressing ICP0.
De-repression mediated by a recombinant
adenovirus expressing ICP0 is associated with an
enrichment of acetylated histones at virus
promoters but not HP1
The ability of an adenovirus vector carrying the ICP0 gene
under the control of the doxycycline/rtTA-inducible
promoter (Ad.TRE.ICP0) to de-repress quiescent HSV-1
genomes was evaluated by superinfecting MRC-5 cells
6 days after infection with in1382 (Fig. 5a). In comparison
with uninduced MRC-5 cells, which exhibited no detect-
able HCMV IE promoter-driven b-galactosidase expression
from resident in1382 genomes, superinfection with a
mixture of Ad.CMV.rtTA and Ad.TRE.ICP0 in the
presence of doxycycline resulted in genome de-repression
and detection of b-galactosidase. The lack of detectable b-
galactosidase following superinfection with either
Ad.CMV.rtTA or Ad.TRE.FXE, carrying a non-functional
copy of ICP0 deleted in the RING finger domain,
confirmed the essential requirement for this functionally
important region of ICP0 in genome de-repression.
Chromatin harvested from either uninduced cells or cells
superinfected with a mixture of Ad.CMV.rtTA and
Ad.TRE.ICP0 were next subjected to ChIP analyses. First,
the impact of adenovirus superinfection on the IP-DNA/
input ratios of cellular GAPDH, TNF-a and c-globin was
examined. Delivery of functional ICP0 did not impact the
level of AcH3 at either transcriptionally active (GAPDH) or
transcriptionally silent (TNF-a, c-globin) genes and had no
impact on nucleosome occupancy as assessed using a
histone H3 C-terminal-specific antibody (Fig. 5b).
Consistent with previous genome-wide studies of nucleo-
some occupancy and histone acetylation (Pokholok et al.,
Fig. 3. (a) ChIP analysis of MRC-5 cells latently infected with
in1382 and, at 6 days p.i., either superinfected (+) or not (”) with
wt HSV-2 strain 333 for 6 h in the presence of PAA. Antibodies
used were anti-acetyl histone H3 (acetyl K9 and K14) (AcH3),
anti-acetyl K9 of histone H3 (AcK9H3), anti-trimethyl K9 histone
H3 (TMK9H3) and anti-HP1-a (HP1). PCRs were performed using
HSV-1 primers to the ICP0 promoter. (b) Model of sequential
repression of chromatin by loss of acetylation markers, gain of
methylation and recruitment of HP1 to trimethylated histone H3.
Fig. 4. ChIP analysis using quantitative real-time PCR. MRC-5
cells were latently infected with in1382 and, at 6 days p.i., either
superinfected or not with wt HSV-2 strain 333 for 0.5, 1, 2 or 4 h.
Antibodies used were (a) anti-acetyl histone H3 (acetyl K9 and
K14) (AcH3), (b) anti-HP1-a (HP1) or (c) anti-trimethyl K9 histone
H3 (TMK9H3). PCRs were performed using primer sets to the
ICP0, ICP27, gC or LAT promoter. Promoter copy number was
quantified by real-time PCR in triplicate and the mean value used
to calculate the IP-DNA/input ratio. This value was then expressed
as a fold change relative to uninduced material. Fold changes were
normalized to GAPDH as described in Methods. Histograms show
fold changes in the level of AcH3, HP1 and TMK9H3 at promoters
against time post-superinfection with HSV-2. The data shown are
representative of three independent experiments.
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displayed a decreased nucleosome occupancy and elevated
association with AcH3 in comparison with the transcrip-
tionally repressed TNF-a or c-globin genes. In contrast to
the inability of ICP0 to increase the association of AcH3
with the cellular genes examined, ICP0 expression resulted
in a marked increase in the IP-DNA/input ratios across a
range of virus promoters (Fig. 5c).
The delivery of functional ICP0 to quiescently infected cells
resulted in an enrichment of AcH3 at all virus promoters
examined and, with the exception of the ICP0 promoter,
the fold change in acetylation increased between 16 and
24 h following adenovirus transduction (Fig. 6a). The
enrichment of AcH3 at virus promoters was dependent on
the RING finger of ICP0, as transduction of quiescently
infected cells with Ad.TRE.FXE did not result in an
Fig. 5. (a) b-Galactosidase staining of MRC-5 cells latently infected (uninduced) with in1382 at 6 days p.i. or superinfected
with HSV-2, Ad.CMV.rtTA (Ad rtTA) alone or Ad rtTA with either Ad.TRE.ICP0 (Ad ICP0) or Ad.TRE.FXE (Ad FXE) in the
presence of doxycycline. ChIP analyses of MRC-5 cells latently infected with in1382, either uninduced (Un) or 24 h after
superinfection with Ad rtTA, Ad ICP0, or Ad FXE. ChIPs were performed with anti-acetyl histone H3 (AcH3) or anti-C-terminal
histone H3-specific (H3) antibodies. (b, c) Real-time PCRs were performed with primer sets to the promoters of GAPDH, TNF-
a and c-globin (b) and to a range of virus promoters as indicated (c). Promoter copy number was quantified by PCR in triplicate
and the mean values used to calculate the IP-DNA/input ratios. The data shown are representative of at least two independent
experiments.
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tent with the inability of this adenovirus vector to induce
b-galactosidase expression from resident in1382 genomes.
In contrast to the modest but reproducible enrichment of
HP1 at virus promoters following HSV-2 superinfection,
delivery of ICP0 using an adenovirus vector did not result
in an obvious enrichment of HP1 at virus promoters
(Fig. 6b). However, a reduction in association of TMK9H3
was observed at virus promoters following ICP0-mediated
de-repression (Fig. 6c). The overwhelming conclusions
from these experiments are that: (i) there is the existence of
a direct correlation between histone acetylation at virus
promoters and HSV genome de-repression; (ii) there is a
dependency on an intact ICP0 RING finger for this effect;
(iii) delivery of ICP0 in isolation does not lead to an
obvious recruitment of HP1; and (iv) de-repression is
associated with a reproducible decrease in association of
TMK9H3.
A striking observation was the lack of uniformity of AcH3
association at different virus promoters following
Ad.TRE.ICP0 infection. Thus, at 24 h after delivery of
Ad.TRE.ICP0, the highest fold changes (.25-fold) were
observed at the VP16, ICP27 and gC promoters with only
an 8-fold change observed at the ICP0 promoter (Fig. 6a).
Fig. 6(d) shows the mean fold change (n55) in AcH3
associated with a range of virus promoters and confirmed
the non-uniform pattern of AcH3 enrichment following
Ad.TRE.ICP0 superinfection. In order to determine
whether the differences observed were influenced by the
Fig. 6. ChIP analyses of MRC-5 cells latently
infected with in1382 and at 6 days p.i.,
superinfected for 16 or 24 h with
Ad.CMV.rtTA (Ad rtTA) and either
Ad.TRE.ICP0 (Ad ICP0) or Ad.TRE.FXE (Ad
FXE) in the presence of doxycycline. (a–c)
ChIPs were performed with anti-acetyl histone
H3 (K9 and K14) (a), anti-HP1-a (b) or anti-
trimethyl K9 histone H3 (TMK9H3) (c). Real-
time PCRs were performed with primer sets to
the promoters of GAPDH, ICP0, gC, ICP27 or
VP16. Promoter copy number was quantified
by PCR in triplicate and the mean value used
to calculate the IP-DNA/input ratio. This value
was then expressed as a fold change relative
to uninduced material (dashed line51). The
data in (c) represent mean fold changes from
three independent experiments (±SEM). (d)
ChIP analyses of MRC-5 cells latently infected
with in1382 and superinfected at 6 days p.i.
for 24 h with Ad rtTA and either Ad ICP0 or Ad
FXE. ChIPs were performed with anti-acetyl
histone H3 (AcH3) or anti-C-terminal histone
H3 (H3)-specific antibodies. Promoter copy
number was quantified by PCR in triplicate and
the mean value used to calculate the IP-DNA/
input ratio. This value was then expressed as a
fold change relative to uninduced material
(dashed line51). Fold changes were normal-
ized to GAPDH as described in Methods.
Histograms show the mean fold changes from
five independent experiments (±SEM). *, P,0.05
versus uninduced material using a two-tailed
Student’s t-test.
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performed a further ChIP assay using an antibody specific
for the C terminus of histone H3, which detects both
modified and unmodified forms of histone H3 (Fig. 6d).
This antibody revealed only minor differences in the fold
change of histone H3 associated with the various test
promoters following Ad.TRE.ICP0 or Ad.TRE.FXE super-
infection, suggesting that nucleosome occupancy at these
promoters is relatively uniform and is unlikely to account
for the relatively large differences in the fold changes of
AcH3 at HSV promoters following ICP0-mediated de-
repression.
DISCUSSION
Previous studies have used replication-defective mutants of
HSV-1 to establish quiescent infection of non-neuronal
cells and have shown that virus genomes adopt a quiescent
state that can efficiently be de-repressed by the provision of
ICP0 in trans (reviewed by Preston, 2000). In this study, we
examined the association of modified histones with
repressed and de-repressed genomes following either
superinfection with HSV-2 or delivery of ICP0 using an
adenovirus vector. Consistent with previous studies,
infection of MRC-5 cells with in1382 resulted in transient
HCMV IE promoter-driven LacZ expression. The inability
to detect LacZ at later times after infection indicated the
establishment of a repressed state that could be reversed
following superinfection with HSV-2 or Ad.TRE.ICP0.
The inability to de-repress quiescent genomes following
superinfection with the HSV-1 ICP0 mutant dl1403 or an
adenovirus containing a non-functional ICP0 gene is
consistent with earlier studies demonstrating a crucial role
for ICP0 in genome de-repression (reviewed by Preston,
2000). The precise mechanism by which ICP0 mediates its
effect is unclear. However the observation that ICP0
expression converts quiescent genomes from a repressed
state characterized by an under-representation of acetylated
histone H3 and H4 to a transcriptionally permissive form
of chromatin enriched with acetylated histones suggests
that a key response to ICP0 is the reversal of histone-
mediated gene silencing.
Our initial studies focused on the association of modified
histones at the ICP0 promoter. ChIP analyses revealed a
relative lack of association of AcH3 and AcH4 at this
promoter during quiescence, with a marked increase in
association of these acetylated histones following HSV-
mediated de-repression. Conversely, during quiescence,
there was a strong association of the repressive TMK9H3
marker and a decrease in association of this modified
histone at the ICP0 promoter following genome de-
repression. Examination of the ICP27, gC and LAT
promoters revealed a similar pattern of association of
acetylated and methylated histone markers during both
quiescence and de-repression, suggesting a global silencing
mechanism associated with an enrichment of repressive
histone markers at promoters, independent of their kinetic
class. Examination of HP1, which is recruited to TMK9H3
and is a characteristic marker of heterochromatic gene
silencing during HCMV latency (Murphy et al., 2002;
Reeves et al., 2005), revealed an association of HP1 with
representative virus promoters during quiescence.
However, de-repression mediated by HSV-2 superinfection
resulted in an increase in association of HP1, with a 2.5–3-
fold enrichment observed 2 h after superinfection. De-
repression mediated by superinfection with Ad.TRE.ICP0
resulted in an enrichment of AcH3 at all virus promoters
examined, but did not result in an increased association of
HP1, suggesting that the recruitment of HP1 to a range of
virus promoters following HSV-2 superinfection could be
the consequence of delivery and/or expression of HSV-2-
encoded gene products. Such a view is not without
precedent, as recent studies of HCMV major IE promoter
regulation have shown that IE86-mediated autorepression
is the result of IE86-mediated changes in chromatin
structure of the viral major IE promoter characterized by
HP1 recruitment (Reeves et al., 2006).
The fold change in association of AcH3 following
Ad.TRE.ICP0-mediated de-repression consistently revealed
promoter-specific variation, with the greatest changes(.50-
fold) being observed at the LAT promoter and enhancer
regions. ChIP analyses using an antibody specific to the C
terminus of histone H3 as a measure of nucleosome
occupancy revealed little variability in nucleosome occu-
pancy at the various HSV promoters. This observation
suggests that acetylation of histone H3 in response to ICP0
expression is more efficiently targeted to regulatory regions
of LAT than other representative virus promoters.
Consistent with our observations for AcH3, examination
of the association of AcH4 at the LAT promoter and
enhancer following ICP0-mediated de-repression has
revealed 22- and 17-fold changes, respectively (unpublished
observations), and experiments are in progress to evaluate
the pattern of acetylation of this histone at distinct virus
promoters following de-repression mediated by ICP0.
Previous in vivo studies have revealed that, during latency,
HSV DNA is retained in a repressed chromatinized state
characterized by the association of hypoacetylated histones
(Kubat et al., 2004a, b) and that LATs may function to
facilitate maintenance of a repressed chromatinized
genome (Wang et al., 2005). Furthermore, following
ganglionic explantation, genome de-repression is linked
to an enrichment of acetylated histones at lytic cycle
promoters and a decrease in LAT enhancer histone
acetylation and LAT RNA abundance (Amelio et al.,
2006). The decrease in histone acetylation at the LAT
enhancer following explant culture of trigeminal ganglia
reported by Amelio et al. (2006) contrasts with the high
level of acetylation at the LAT regulatory region observed
following ICP0-mediated de-repression observed in the
current study. The most likely explanation for this
apparently contradictory result is that analyses of sensory
ganglia at early times post-explant (1–2 h) facilitates an
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histones at LAT regulatory regions prior to the expression
of ICP0. In the current study, which utilized a non-
neuronal in vitro latency model system, the acetylation of
histones at virus promoters was dependent on ICP0
expression and may therefore reflect events that occur at
later stages of virus reactivation following the expression of
ICP0. The increased acetylation observed at the LAT
promoter/enhancer in response to ICP0 protein expression
could function to activate LAT transcription in order to
antagonize lytic phase transcription and provide an
additional checkpoint in the regulation of reactivation.
Our studies have utilized an in vitro model system to
examine the nature of modified histones associated with
virus genomes during quiescence and have revealed that, in
the absence of virus gene expression, input genomes are
effectively silenced and associated with histone markers
characteristic of inactive chromatin. These results accord
with recent data reporting an association of rapid gene
silencing and the formation of inactive chromatin of HSV
amplicon-based vectors (Suzuki et al., 2006). The obser-
vation that ICP0-mediated de-repression of quiescent
genomes is associated with enrichment of active histone
markers at virus promoters is consistent with reports
demonstrating an interaction of ICP0 with histone
deacetylases (HDACs) (Lomonte et al., 2004) and its
ability to dissociate HDAC 1 and 2 from the CoREST/
REST complex (Gu et al., 2005). It would therefore appear
that the ICP0 gene product plays a key role in antagonizing
genomic silencing in the in vitro model system described.
Whether ICP0 plays a similar crucial role at the earliest
stages of reactivation from latency in sensory neurones is
less clear. Unlike non-neuronal model systems of HSV
quiescence, which are dependent on ICP0 for genome de-
repression, reactivation from sensory neurones can be
mediated by a wide variety of external stimuli.
Furthermore, the observation that ICP0-deficient mutants
can initiate virus gene expression in a proportion (,0.1%)
of latently infected neurones in vivo suggests that an ICP0-
independent mechanism of de-repression operates in this
subset of neurones (Thompson & Sawtell, 2006). Further
studies are clearly warranted to determine the requirement
for ICP0 in genome de-repression and induction of
reactivation in the majority of latently infected neurones
that are refractory to external stimuli.
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